Psychometric Validation of the Child Health Questionnaire (CHQ) in a Sample of Children and Adolescents with Attention-deficit/hyperactivity Disorder

Overview

Journal Qual Life Res

Specialties Pharmacology
Rehabilitation Medicine

Date 2005 Jul 19

PMID 16022065

Citations 32

Authors

Anne M Rentz

Louis S Matza

Kristina Secnik

Andrine Swensen

Dennis A Revicki

Affiliations

Soon will be listed here.

Abstract

Measuring health-related quality of life (HRQL) in children with attention-deficit/hyperactivity disorder (ADHD) in clinical trials can complement efficacy measures, offering a complete picture of the impact of disease and treatment on overall well-being. The purpose of the current study was to psychometrically validate a multidimensional, generic HRQL instrument completed by parents of children with ADHD. A total of 921 children and adolescents with ADHD participated in a clinical study of atomoxetine. Subjects' parents completed the 50-item Child Health Questionnaire-Parent Version (CHQ-PF50) at baseline and week 10. ADHD symptoms and behavioral problems were assessed using parent and clinician rating scales. Internal consistency reliability at baseline was 0.88 for the CHQ-PF50 Psychosocial Summary Score, ranging from 0.53 to 0.91 for subscale scores. Construct validity was supported by statistically significant correlations between CHQ-PF50 psychosocial scores and parent and clinician symptom ratings. Several methods were used to determine clinically meaningful differences in patient outcomes: inter- and intra-patient mean CHQ-PF50 change scores were tested and standard error of measurement (SEM) and effect sizes were calculated. Study results indicate the CHQ-PF50 is reliable, valid, and responsive to change in ADHD symptoms, suggesting it may provide a means of assessing HRQL outcomes associated with treatments for ADHD.

Citing Articles

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Storebo O, Storm M, Ribeiro J, Skoog M, Groth C, Callesen H Cochrane Database Syst Rev. 2023; 3:CD009885.

PMID: 36971690 PMC: 10042435. DOI: 10.1002/14651858.CD009885.pub3.

Development and Validation of the Pediatric Charcot-Marie-Tooth Disease Quality of Life Outcome Measure.

Ramchandren S, Wu T, Finkel R, Siskind C, Feely S, Burns J Ann Neurol. 2020; 89(2):369-379.

PMID: 33222249 PMC: 11671102. DOI: 10.1002/ana.25966.

Assessing quality of life in psychosocial and mental health disorders in children: a comprehensive overview and appraisal of generic health related quality of life measures.

Mierau J, Kann-Weedage D, Hoekstra P, Spiegelaar L, Jansen D, Vermeulen K BMC Pediatr. 2020; 20(1):329.

PMID: 32620157 PMC: 7333319. DOI: 10.1186/s12887-020-02220-8.

Measuring Health-Related Quality of Life in Pediatric Neurology.

Lemmon M, Huffstetler H, Reeve B J Child Neurol. 2020; 35(10):681-689.

PMID: 32498657 PMC: 7415579. DOI: 10.1177/0883073820923809.

Validation of the Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD) in a sample of Turkish non-ambulatory children with cerebral palsy.

Simsek T, Sertel M, Tutun Yumin E, Aras B, Narayanan U Turk Pediatri Ars. 2019; 54(1):13-27.

PMID: 31217705 PMC: 6559974. DOI: 10.14744/TurkPediatriArs.2019.57778.

References

Sprangers M, Moinpour C, Moynihan T, Patrick D, Revicki D . Assessing meaningful change in quality of life over time: a users' guide for clinicians. Mayo Clin Proc. 2002; 77(6):561-71. DOI: 10.4065/77.6.561. View

Guyatt G, Osoba D, Wu A, Wyrwich K, Norman G . Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002; 77(4):371-83. DOI: 10.4065/77.4.371. View

Waters E, Salmon L, Wake M, Hesketh K, Wright M . The Child Health Questionnaire in Australia: reliability, validity and population means. Aust N Z J Public Health. 2000; 24(2):207-10. DOI: 10.1111/j.1467-842x.2000.tb00145.x. View

Landgraf J, Rich M, Rappaport L . Measuring quality of life in children with attention-deficit/hyperactivity disorder and their families: development and evaluation of a new tool. Arch Pediatr Adolesc Med. 2002; 156(4):384-91. DOI: 10.1001/archpedi.156.4.384. View

Rugino T, Copley T . Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study. J Am Acad Child Adolesc Psychiatry. 2001; 40(2):230-5. DOI: 10.1097/00004583-200102000-00018. View

Leidy N, Revicki D, Geneste B . Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health. 2006; 2(2):113-27. DOI: 10.1046/j.1524-4733.1999.02210.x. View

Crosby R, Kolotkin R, Williams G . Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003; 56(5):395-407. DOI: 10.1016/s0895-4356(03)00044-1. View

Ghuman J, Ginsburg G, Subramaniam G, Ghuman H, Kau A, Riddle M . Psychostimulants in preschool children with attention-deficit/hyperactivity disorder: clinical evidence from a developmental disorders institution. J Am Acad Child Adolesc Psychiatry. 2001; 40(5):516-24. DOI: 10.1097/00004583-200105000-00010. View

Revicki D, Rentz A, Dubois D, Kahrilas P, Stanghellini V, Talley N . Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther. 2003; 18(1):141-50. DOI: 10.1046/j.1365-2036.2003.01612.x. View

10.

Barkley R, DuPaul G, McMurray M . Comprehensive evaluation of attention deficit disorder with and without hyperactivity as defined by research criteria. J Consult Clin Psychol. 1990; 58(6):775-89. DOI: 10.1037//0022-006x.58.6.775. View

11.

Kazis L, Anderson J, Meenan R . Effect sizes for interpreting changes in health status. Med Care. 1989; 27(3 Suppl):S178-89. DOI: 10.1097/00005650-198903001-00015. View

12.

Coyne K, Wiklund I, SCHMIER J, Halling K, Degl Innocenti A, Revicki D . Development and validation of a disease-specific treatment satisfaction questionnaire for gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2003; 18(9):907-15. DOI: 10.1046/j.1365-2036.2003.01674.x. View

13.

Spies J, Coyne K, Guaou N, Boyle D, Gonzalves S . The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002; 99(2):290-300. DOI: 10.1016/s0029-7844(01)01702-1. View

14.

Barkley R, Fischer M, Edelbrock C, Smallish L . The adolescent outcome of hyperactive children diagnosed by research criteria--III. Mother-child interactions, family conflicts and maternal psychopathology. J Child Psychol Psychiatry. 1991; 32(2):233-55. DOI: 10.1111/j.1469-7610.1991.tb00304.x. View

15.

Palermo T, Schwartz L, Drotar D, McGowan K . Parental report of health-related quality of life in children with sickle cell disease. J Behav Med. 2002; 25(3):269-83. DOI: 10.1023/a:1015332828213. View

16.

Kadesjo C, Kadesjo B, Hagglof B, Gillberg C . ADHD in Swedish 3- to 7-year-old children. J Am Acad Child Adolesc Psychiatry. 2001; 40(9):1021-8. DOI: 10.1097/00004583-200109000-00010. View

17.

Kratochvil C, Heiligenstein J, Dittmann R, Spencer T, Biederman J, Wernicke J . Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry. 2002; 41(7):776-84. DOI: 10.1097/00004583-200207000-00008. View

18.

Wilens T, Biederman J, Abrantes A, Spencer T . A naturalistic assessment of protriptyline for attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1996; 35(11):1485-90. DOI: 10.1097/00004583-199611000-00017. View

19.

Waters E, Salmon L, Wake M . The parent-form Child Health Questionnaire in Australia: comparison of reliability, validity, structure, and norms. J Pediatr Psychol. 2000; 25(6):381-91. DOI: 10.1093/jpepsy/25.6.381. View

20.

Asmussen L, Olson L, Grant E, Landgraf J, Fagan J, Weiss K . Use of the child health questionnaire in a sample of moderate and low-income inner-city children with asthma. Am J Respir Crit Care Med. 2000; 162(4 Pt 1):1215-21. DOI: 10.1164/ajrccm.162.4.2001067. View